Management of anaphylactic shock in the emergency department: A literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v13i9.46826

Keywords:

Anaphylactic shock; Emergency management; Epinephrine; Airway; Intravenous fluids; Emergency protocols; Patient education.

Abstract

Anaphylactic shock is a severe and potentially fatal allergic reaction that requires immediate intervention. This literature review aims to analyze the management strategies for anaphylactic shock in the emergency department, emphasizing the importance of early administration of epinephrine, airway maintenance, and intravenous fluid administration. The research was conducted in the databases Google Scholar, LILACS, and SCIELO, covering publications from 2000 to 2024 in Portuguese, English, and Spanish. The results indicate that the lack of knowledge and adequate training among healthcare professionals can delay treatment, exacerbating the severity of the condition. Furthermore, the review highlights the need for standardized protocols and continuous education of healthcare professionals to improve patient outcomes. Patient education and prevention of future reactions are critical components of anaphylactic shock management, underscoring the importance of preventive strategies and long-term follow-up.

References

Anderson, J. L., & Morrow, D. A. (2017). Acute coronary syndrome. New England Journal of Medicine, 376(14), 1283-1295.

Bohlke, K., Davis, R. L., DeStefano, F., Marcy, S. M., Braun, M. M., Thompson, R. S., ... & Mullooly, J. P. (2003). Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. Journal of Allergy and Clinical Immunology, 113(3), 536-542.

Brown, S. G. (2004). Clinical features and severity grading of anaphylaxis. Journal of Allergy and Clinical Immunology, 114(2), 371-376.

Cardona, V., Ansotegui, I. J., Ebisawa, M., El-Gamal, Y., Fernandez Rivas, M., Fineman, S., ... & Sheikh, A. (2020). World allergy organization anaphylaxis guidance 2020. World Allergy Organization Journal, 13(10), 100472.

Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., ... & Widimsky, P. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 39(2), 119-177.

Järvinen, K. M., & Sicherer, S. H. (2012). Epidemiology of anaphylaxis. Immunology and Allergy Clinics, 32(1), 1-17.

Kemp, S. F., Lockey, R. F., Simons, F. E., & World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. (2008). Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy, 63(8), 1061-1070.

Lieberman, P., Nicklas, R. A., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, J., ... & Wallace, D. (2015). Anaphylaxis—a practice parameter update 2015. Annals of Allergy, Asthma & Immunology, 115(5), 341-384.

Muraro, A., Roberts, G., Worm, M., Bilò, M. B., Brockow, K., Fernández Rivas, M., ... & Sheikh, A. (2014). Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy, 69(8), 1026-1045.

Pumphrey, R. S. (2000). Lessons for management of anaphylaxis from a study of fatal reactions. Clinical and Experimental Allergy, 30(8), 1144-1150.

Ring, J., Beyer, K., Biedermann, T., Bircher, A., Duda, D., Fischer, J., ... & Worm, M. (2014). Guideline for acute therapy and management of anaphylaxis. Allergo Journal International, 23(3), 96-112.

Sheikh, A., Shehata, Y. A., Brown, S. G., & Simons, F. E. (2009). Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy, 64(2), 204-212.

Simons, F. E. (2010). Anaphylaxis. Journal of Allergy and Clinical Immunology, 125(2), S161-S181.

Simons, F. E., Ardusso, L. R., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., ... & World Allergy Organization. (2011). World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organization Journal, 4(2), 13-37.

Simons, F. E., Ardusso, L. R., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., ... & World Allergy Organization. (2015). Update: World Allergy Organization anaphylaxis guidelines: 2015. World Allergy Organization Journal, 8(1), 32.

Simons, K. J., & Simons, F. E. (2012). Epinephrine and its use in anaphylaxis: current issues. Current Opinion in Allergy and Clinical Immunology, 12(4), 354-361.

Sicherer, S. H., & Sampson, H. A. (2014). Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment. Journal of Allergy and Clinical Immunology, 133(2), 291-307.

Turner, P. J., Jerschow, E., Umasunthar, T., Lin, R., Campbell, D. E., & Boyle, R. J. (2017). Fatal anaphylaxis: Mortality rate and risk factors. Journal of Allergy and Clinical Immunology, 139(2), 556-567.

Wood, R. A., Camargo Jr, C. A., Lieberman, P., Sampson, H. A., Schwartz, L. B., Zitt, M., & Collins, M. (2014). Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. Journal of Allergy and Clinical Immunology, 133(2), 461-467.

Worm, M., Moneret-Vautrin, A., Scherer, K., Lang, R., Fernandez-Rivas, M., Cardona, V., ... & Beyer, K. (2014). First European data from the network of severe allergic reactions (NORA). Allergy, 69(10), 1397-1404

Published

18/09/2024

How to Cite

MEDEIROS, F. de A.; OLIVEIRA, L. H. V. .; BRANDT, R. P.; SILVA, R. N. .; ARAÚJO, M. E. S. da S. de .; TANO, V. de L. F. .; OLIVEIRA, P. G. K. de .; FONSECA, M. G. da .; SILVA, W. S. .; DAYUBE, C. de O. P. R. .; COSTA, H. S. .; BRIGIDO, C. E. P. L. .; SILVA, C. B. do V. .; SILVA, M. D. .; GIACOMAZZI, G. . Management of anaphylactic shock in the emergency department: A literature review. Research, Society and Development, [S. l.], v. 13, n. 9, p. e5613946826, 2024. DOI: 10.33448/rsd-v13i9.46826. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/46826. Acesso em: 27 sep. 2024.

Issue

Section

Health Sciences